Invex Therapeutics (ASX:IVX)
Invex has received an approval from the UK’s MHRA to commence its IIH EVOLVE Phase III clinical trial in the country. The trial will study patients with Idiopathic Intracranial Hypertension (IIH), and they will be randomly treated with Presendin versus placebo once weekly over 24 weeks.
- Forums
- ASX - By Stock
- IVX
- New UK Clinical Trial
New UK Clinical Trial
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IVX (ASX) to my watchlist
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.41M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $72 | 18K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
25 | 10334314 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 6053724 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
25 | 10334314 | 0.004 |
19 | 14440755 | 0.003 |
4 | 3900000 | 0.002 |
8 | 13200000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 5991224 | 24 |
0.006 | 3871276 | 12 |
0.007 | 3277309 | 5 |
0.008 | 4842200 | 6 |
0.009 | 2650299 | 8 |
Last trade - 15.42pm 12/07/2024 (20 minute delay) ? |
Featured News
IVX (ASX) Chart |